![]() Núria Casals has published four articles in international journals about their research into the effects of Nucleo CMP Forte. The group is currently studying the neuronal regeneration effect of the drug Nucleo CMP-Forte in co-cultures of Schwann cells and neurons. Since 2007, the group has been researching the effect of the same drug on Schwann cells in the treatment of peripheral neuropathies and the regeneration of the peripheral nervous system. From 2003 to 2006, the effect of the drug Nucleo CMP-Forte on nerve cells was studied. The collaboration has continued for 13 years.įrom 1999 to 2002, the protective effects of the drug Citicolina on neuronal cell death was studied. Núria Casals, began in 1999 with a scientific collaboration with Ferrer to study the action mechanism of different drugs. M09A - Otros farmacos para desordenes del sistema musculoesqueltico. The Pharmacology Area of the UIC Faculty of Medicine and Health Sciences, directed by Dr. M09 - Otros medicamentos para desorden del sist. Núria Casals, the Head of the Nucleo CMP-Forte Ferrer Programme, attended the signing. Albert Balaguer, the Dean of the Faculty of Medicine and Health Sciences and Dr. La administracin del frmaco Nucleo C.M.P Forte (CMP/UMP) compuesto por dos nucletidos, citosina. Lorenzo, the Medical Director were present at the signing of the agreement. La causa de la fatiga muscular no est bien comprendida. Farmacocinética y farmacodinamia: Farmacocinética: El producto farmacéutico NÚCLEO CMP es una asociación de 2 nucleótidos: CMP y UTP. Joaquim Delgadillo, the Director of Clinical Development and Dr. Indicaciones terapéuticas: Para el tratamiento de las neuropatías periféricas de origen osteoarticular, metabólico, infeccioso, y a frigore. ![]() Fernando García Alonso, the Director of the Scientific Area Dr.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |